Evidence map›Paper›PMID 41320877›Full record

ReviewZoological research2025

Diverse species of animal models in epilepsy research: Progress and perspectives.

Wang-Jia-Lu Lu, Jing Xi, Zhi-Sheng Li, Fan Fei, Jun-Zi Chen, Yi Wang

Abstract readReview
In one paragraph

Review in Zoological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wang-Jia-Lu LuKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Department of Pharmacology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
Jing XiKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Department of Pharmacology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
Zhi-Sheng LiKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Department of Pharmacology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
Fan FeiZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Jun-Zi ChenZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. E-mail: chen19857016387@163.com.
Yi WangKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Department of Pharmacology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy, a prevalent neurological disorder, is characterized by recurrent, self-sustained seizures resulting from abnormal neuronal hyperexcitability. Epilepsy encompasses a wide spectrum of etiologies, pathophysiological mechanisms, and treatment responses, resulting in considerable phenotypic heterogeneity. Over the past few decades, animal models, ranging from simple organisms to complex species, have played a pivotal role in elucidating the cellular, molecular, and circuit mechanisms underlying seizure generation and propagation, while also facilitating the development of antiseizure medication and other therapeutic interventions. This review first outlines the mechanistic basis of epilepsy and systematically summarizes existing seizure and epilepsy models across diverse taxa, including zebrafish, rodents, and non-human primates (NHPs), with a focus on model-specific features, translational relevance, and therapeutic utility. Despite substantial progress, limitations persist in recapitulating the full complexity of human epilepsy. Recent advances in genetic engineering, neuromodulation technology, and brain organoids are refining model fidelity and enhancing alignment with precision medicine approaches. Cross-species integration offers a promising avenue for bridging preclinical findings with clinical application, advancing mechanistic insight, and the development of targeted therapies.

Indexed as

Disease Models, AnimalEpilepsyAnimalsHumansSpecies SpecificityAnimal modelAntiseizure medicationCross-speciesEpilepsyPrecision medicineSeizure

Identifiers

PMID41320877
PMCPMC12950520

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.